Plasmacytoid urothelial carcinoma is rare and aggressive, with poor outcomes and challenges in accurate staging. National and institutional data reveal discrepancies in chemotherapy use and disease ...

In this video, Fed Ghali, MD, highlights key findings from the study, “Evaluating Clinical Outcomes and the Role of Neoadjuvant Chemotherapy in Plasmacytoid Urothelial Carcinoma: Insights from a ...

Drug-induced hyponatremia is an adverse reaction with accelerated electrolyte disturbance. This study reported a rare case of delayed hyponatremia in a 68year-old female with recurrent upper tract ...

Objective: To investigate the optimal cut-off value of immunohistochemical marker Ki67 as a prognostic factor to predict the recurrence of non-muscle invasive bladder urothelial carcinoma (NMIBUC).

Other types include squamous cell carcinoma or adenocarcinoma, which develop in the inner lining of the bladder. The proteomic landscape of muscle-invasive bladder cancer (MIBC) in the context of ...

Treatment Options for Bladder Cancer: Bringing Life to Years of Sparse Options - Guru Sonpavde ...

epithelioid and plasmacytoid forms, causing significant diagnostic dilemmas. The coexpression of at least one epithelial marker and S-100 or GFAP protein is required for the diagnosis. Here we report ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

It was there that a biopsy uncovered the truth: Armando had Stage 4 metastatic urothelial carcinoma (mUC), also known as advanced bladder cancer. Bladder cancer is a serious, challenging disease ...

Prevalence of high-risk human papillomavirus in primary squamous cell carcinoma of urinary bladder. Pathol Res Pract. 2020 Sep;216(9):153084. doi: 10.1016/j.prp.2020.153084. Epub 2020 Jun 23. PMID: ...